jueves, 4 de noviembre de 2021

Emerging SARS-CoV-2 variant A.30 efficiently evades vaccine-induced immunity

Emerging SARS-CoV-2 variant A.30 efficiently evades vaccine-induced immunity

No hay comentarios:

Publicar un comentario